VICENTE ANIDO JR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for VICENTE ANIDO JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of VICENTE ANIDO JR. VICENTE ANIDO JR is a Director in DEPOMED INC ($DMI) and a President & CEO in ISTA PHARMACEUTICALS INC ($ISTA) and an Chief Executive Officer in AERIE PHARMACEUTICALS INC ($AERI).
Address: 15279 ALTON PARKWAY SUITE 100 IRVINE 92618 CA
Companies in which VICENTE ANIDO JR is an Insider
AERIE PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of VICENTE ANIDO JR: Chief Executive Officer
Holdings: 233,396 shares
Current Value: $9,989,349
Latest Transaction: Feb 25 2021
$AERI Market Capitalization: $1.50B
$AERI Previous Close: $42.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Assertio Therapeutics, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VICENTE ANIDO JR: Director
Holdings: 4,403 shares
Latest Transaction: May 13 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ISTA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VICENTE ANIDO JR: President & CEO
Holdings: 415,067 shares
Latest Transaction: Feb 18 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of VICENTE ANIDO JR
Sentiment: All, AERI, DMI, ISTA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 15.66 | 1,700 | 26,622 | 233,396 | 235.1 K to 233.4 K (-0.72 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 17.72 | 2,500 | 44,300 | 235,096 | 237.6 K to 235.1 K (-1.05 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 17.68 | 2,496 | 44,129 | 237,596 | 240.1 K to 237.6 K (-1.04 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 17.68 | 2,958 | 52,297 | 240,092 | 243.1 K to 240.1 K (-1.22 %) |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 17.64 | 125,000 | 2,205,000 | 125,000 | |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 28,000 | 0 | 243,050 | 215.1 K to 243.1 K (+13.02 %) |
| May 18 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 14.85 | 4,746 | 70,454 | 215,050 | 219.8 K to 215.1 K (-2.16 %) |